Furthermore, RyR-mediated Ca2+ release upregulates secretases, increasing APP cleavage, Aβ fragments, and plaque deposition, and its blockage leads to Aβ reduction and improved memory impairment [101]. The gene discussed is RYR2; the disease is memory impairment.